As of October 2024 Axsome Therapeutics has a market cap of ₹334.64 Billion. This makes Axsome Therapeutics the world's 3101th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Oct 9th, 2024 the market cap of Axsome Therapeutics was reported to be: